Don't show this message again
Maureen Burger, Chief Nursing Officer, Visante.
2021-10-12
-
Identify one change in DEA rules due to COVID-19
-
Describe at least two workflow changes during COVID-19 that created unintended opportunities for diversion
-
Relate human responses to COVID-19 and impact on rate of drug diversion in healthcare
-
Evaluate three drug diversion risk mitigation strategies